MOLOGEN Lifescience AG (DB: U1DA)
Consumer Discretionary · Specialty Retail · DE
€2.80
-21.35% today · -3.4% 1Y
MOLOGEN Lifescience AG (DB: U1DA) operates in the Specialty Retail industry within the Consumer Discretionary sector. The company is valued at $4.35M and employs 2 people.
Over the last twelve months the share price has lost 3.4%, trading between 1.80 and 4.50.
Tweenvest scores MOLOGEN Lifescience AG across four factors: quality 49/100. Its strongest factor is quality.
U1DA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.35M
- Revenue (TTM)
- $47.17K
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.50
- 52-week high
- €4.50
- 52-week low
- €1.80
- Avg volume (3M)
- —
- Shares outstanding
- 1.38M
- Employees
- 2
- Next earnings
- —
About MOLOGEN Lifescience AG
Finchain Capital Partners AG functions as an investment firm, concentrating its capital deployment on early-stage companies, specifically during their seed, Series A, and Series B funding rounds. The company was established on February 27, 2015, and is based in Dusseldorf, Germany.
- ISIN
- DE000A3MQC96
- Founded
- 2015
- Listed since
- Aug 18, 2016
- Exchange
- Deutsche Boerse AG
- Currency
- EUR
Other Specialty Retail companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hunter Capital AB (publ)NGM: HUNTER | $4.69M | Skr10.35 | -2.36% |
| Boutique Newcity Public Company LimitedSET: BTNC | $4.65M | ฿13.00 | -2.26% |
| Digital Brands Group, Inc.NasdaqCM: DBGI | $4.55M | $4.50 | -7.60% |
| Harris Technology Group LimitedASX: HT8 | $4.42M | AU$0.02 | -10.53% |
| Archies LimitedNSEI: ARCHIES | $4.34M | Rs12.37 | +0.57% |
| Xcel Brands, Inc.NasdaqCM: XELB | $4.31M | $0.64 | -2.59% |
| PT Omni Inovasi Indonesia TbkIDX: TELE | $4.06M | Rp— | — |
| Petro USA, Inc.OTCPK: PBAJ | $4.01M | $— | — |
Figures last refreshed Oct 4, 2026.